Figures & data
Table 1 Sociodemographic Characteristics of Women with Breast Cancer Attending Oncology Center at TASH, Addis Ababa, Ethiopia, 2019 (N=209)
Table 2 Patient-related Variables of Women with Breast Cancer Attending Oncology Center at TASH, Addis Ababa, Ethiopia, 2019 (N=209)
Table 3 Disease-related Variables of Women with Breast Cancer Attending Oncology Center at TASH, Addis Ababa, Ethiopia, 2019 (N=209)
Figure 1 Side effects of adjuvant hormonal therapy’s reported by the respondents among women with breast cancer attending oncology center at TASH, Addis Ababa, Ethiopia, 2019 (N=209).
![Figure 1 Side effects of adjuvant hormonal therapy’s reported by the respondents among women with breast cancer attending oncology center at TASH, Addis Ababa, Ethiopia, 2019 (N=209).](/cms/asset/02fa4c67-99bb-4b1c-b0ed-caef9677f3d9/dbct_a_34135629_f0001_b.jpg)
Table 4 Medication-Related Variables of Women with Breast Cancer Attending Oncology Center at TASH, Addis Ababa, Ethiopia, 2019 (N=209)
Table 5 Health-care System-Related Factors of Women with Breast Cancer Attending Oncology Center at TASH, Addis Ababa, Ethiopia, 2019 (N=209)
Figure 2 AHT adherence among women with breast cancer attending oncology center at TASH, Addis Ababa, Ethiopia, 2019 (N=209).
![Figure 2 AHT adherence among women with breast cancer attending oncology center at TASH, Addis Ababa, Ethiopia, 2019 (N=209).](/cms/asset/44f20eaa-fa4a-44af-a14d-cacca69850c3/dbct_a_34135629_f0002_b.jpg)
Table 6 Bivariate and Multivariate Analysis of Factors Associated with Adherence to AHT Among Women with Breast Cancer Attending Oncology Center at TASH, Addis Ababa, Ethiopia, 2019